![Russell Hawkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Hawkinson
Keine laufenden Positionen mehr
Profil
Russell Hawkinson worked as Vice President-Finance & Accounting at CTI BioPharma Corp.
from 2006 to 2007.
He then worked as Vice President-Finance at Corixa Corp.
from 1995 to 2005.
From 2007 to 2018, he served as Chief Financial Officer at Theraclone Sciences, Inc. He also worked as an Audit Senior Manager at Ernst & Young LLP (Missouri).
In addition, he worked as Chief Financial Officer at OncoResponse, Inc. from 2015 to 2018.
Most recently, he served as Senior Vice President-Finance at Silverback Therapeutics, Inc. from 2020 to 2022.
Mr. Hawkinson received his undergraduate degree from the University of Washington.
Ehemalige bekannte Positionen von Russell Hawkinson
| Unternehmen | Position | Ende |
|---|---|---|
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Finanzdirektor/CFO | 01.06.2018 |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Finanzdirektor/CFO | 01.06.2018 |
| CTI BIOPHARMA CORP. | Finanzdirektor/CFO | 01.01.2007 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Finanzdirektor/CFO | 01.01.2005 |
| ARS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | - |
Ausbildung von Russell Hawkinson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
